What is a stock summary page? Click here for an overview.
Business Description
Nuo Therapeutics Inc
NAICS : 325414
SIC : 2836
ISIN : US67059V2097
Share Class Description:
AURX: Ordinary SharesDescription
Nuo Therapeutics Inc is a regenerative therapies company focused on developing and marketing products for chronic wound care primarily within the U.S. Company's commercialize innovative cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The company derives revenues from the sale of the Aurix product to customers consisting of primarily hospital outpatient wound care clinics and other private practice physicians treating chronic wounds.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.8 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 15.89 | |||||
| Beneish M-Score | -2.02 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -231.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 7.7 | |||||
| 9-Day RSI | 24.24 | |||||
| 14-Day RSI | 34.04 | |||||
| 3-1 Month Momentum % | -26.53 | |||||
| 6-1 Month Momentum % | 112.45 | |||||
| 12-1 Month Momentum % | 25.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.88 | |||||
| Quick Ratio | 1.65 | |||||
| Cash Ratio | 0.96 | |||||
| Days Inventory | 286.36 | |||||
| Days Sales Outstanding | 84.25 | |||||
| Days Payable | 582.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.4 | |||||
| Shareholder Yield % | 0.15 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 77.83 | |||||
| Operating Margin % | -212.33 | |||||
| Net Margin % | -212.33 | |||||
| FCF Margin % | -206.42 | |||||
| ROE % | -345.6 | |||||
| ROA % | -157.76 | |||||
| ROIC % | -646.17 | |||||
| ROC (Joel Greenblatt) % | -708.17 | |||||
| ROCE % | -286.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 51.92 | |||||
| PB Ratio | 67.5 | |||||
| Price-to-Tangible-Book | 67.5 | |||||
| EV-to-EBIT | -22.11 | |||||
| EV-to-EBITDA | -22.98 | |||||
| EV-to-Revenue | 46.94 | |||||
| EV-to-FCF | -25.81 | |||||
| Price-to-Net-Current-Asset-Value | 135 | |||||
| Earnings Yield (Greenblatt) % | -4.52 | |||||
| FCF Yield % | -3.83 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AURX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nuo Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.168 | ||
| EPS (TTM) ($) | -0.06 | ||
| Beta | -1100.73 | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 5187.22 | ||
| Volatility % | 163.23 | ||
| 14-Day RSI | 34.04 | ||
| 14-Day ATR ($) | 0.033261 | ||
| 20-Day SMA ($) | 1.282525 | ||
| 12-1 Month Momentum % | 25.11 | ||
| 52-Week Range ($) | 0.252 - 1.76 | ||
| Shares Outstanding (Mil) | 46.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nuo Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nuo Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nuo Therapeutics Inc Frequently Asked Questions
What is Nuo Therapeutics Inc(AURX)'s stock price today?
The current price of AURX is $1.35. The 52 week high of AURX is $1.76 and 52 week low is $0.25.
When is next earnings date of Nuo Therapeutics Inc(AURX)?
The next earnings date of Nuo Therapeutics Inc(AURX) is 2025-05-15 Est..
Does Nuo Therapeutics Inc(AURX) pay dividends? If so, how much?
Nuo Therapeutics Inc(AURX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers